Compounds > 3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide
Page last updated: 2024-11-13
3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide
Description
pydiflumetofen: succinate dehydrogenase inhibitor (SDHI) fungicide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
pydiflumetofen : A racemate comprising equimolar amounts of (R)- and (S)-pydiflumetofen. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
3-(difluoromethyl)-N-methoxy-1-methyl-N-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 3-(difluoromethyl)-1-methylpyrazole-4-carboxylic acid with the amino group of N-methoxy-1-(2,4,6-trichlorophenyl)propan-2-amine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
Synonyms (26)
Synonym |
SCHEMBL621538 |
3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid methoxy-[1-methyl-2-(2,4,6-trichloro-phenyl)-ethyl]amide |
3-difluoromethyl-1-methyl-1h-pyrazole-4-carboxylic acid methoxy-[1-methyl-2-(2,4,6-trichloro-phenyl)-ethyl]-amide |
3-(difluoromethyl)-n-methoxy-1-methyl-n-[1-(2,4,6-trichlorophenyl)propan-2-yl]pyrazole-4-carboxamide |
CHEBI:87576 |
3-(difluoromethyl)-n-methoxy-1-methyl-n-[1-(2,4,6-trichlorophenyl)propan-2-yl]-1h-pyrazole-4-carboxamide |
1228284-64-7 |
whg7i49fak , |
unii-whg7i49fak |
3-(difluoromethyl)-n-methoxy-1-methyl-n-(1-methyl-2-(2,4,6-trichlorophenyl)ethyl)-1h-pyrazole-4-carboxamide |
1h-pyrazole-4-carboxamide, 3-(difluoromethyl)-n-methoxy-1-methyl-n-(1-methyl-2-(2,4,6-trichlorophenyl)ethyl)- |
pydiflumetofen |
pydiflumetofen [iso] |
3-(difluoromethyl)-n-methoxy-1-methyl-n-((rs)-1-methyl-2-(2,4,6-trichlorophenyl)ethyl)-1h-pyrazole-4-carboxamide |
3-(difluoromethyl)-n-methoxy-1-methyl-n-((2.xi.)-1-(2,4,6-trichlorophenyl)propan-2-yl)-1h-pyrazole-4-carboxamide |
DTXSID60894826 |
Q27159744 |
adepidyn |
mfcd31718936 |
3-(difluoromethyl)-n-methoxy-1-methyl-n-(1-(2,4,6-trichlorophenyl)propan-2-yl)-1h-pyrazole-4-carboxamide |
3-(difluoromethyl)-n-methoxy-1-methyl-n-[1-methyl-2-(2,4,6-trichlorophenyl)ethyl]-1h-pyrazole-4-carboxamide; 3-(difluoromethyl)-n-methoxy-1-methyl-n-[1-(2,4,6-trichlorophenyl)propan-2-yl]-1h-pyrazole-4-carboxamide; adepidyn; pydiflumetofen |
3-(difluoromethyl)-n-methoxy-1-methyl-n-[1-(2,4,6-trichlorophenyl) propan-2-yl]pyrazole-4-carboxamide |
EN300-6495150 |
CS-0611991 |
HY-150127 |
Z2943875904 |
Drug Classes (5)
Class | Description |
trichlorobenzene | Any member of the class of chlorobenzenes carrying three chloro substituents at unspecified positions. |
monocarboxylic acid amide | A carboxamide derived from a monocarboxylic acid. |
aromatic amide | An amide in which the amide linkage is bonded directly to an aromatic system. |
pyrazoles | |
organofluorine compound | An organofluorine compound is a compound containing at least one carbon-fluorine bond. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (20)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (5.00) | 24.3611 |
2020's | 19 (95.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.86
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.86 (24.57) | Research Supply Index | 3.04 (2.92) | Research Growth Index | 5.91 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 20 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |